本季度信息
根据公告披露，截至2025年9月30日止九个月，正大企业国际录得未经审核股东应占综合净利润约2350万美元，同比增长约447%（去年同期为430万美元）。该增长主要来自收入的显著提升，得益于重点开发大客户销售策略的成效。同期表现显示，2025年第三季度的净利润约为650万美元，较2025年第二季度的930万美元有所回落，原因在于中国畜牧业放缓，带动动保化药产品需求自第三季度起走软。
业务分项
公告显示，动保化药产品板块受宏观环境影响，第三季度需求明显下降；但整体业务营收依旧保持增长态势。公司在大客户开发上的持续投入，对收入贡献度提升明显。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.